Rapid Micro Biosystems (RPID) Share-based Compensation (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Share-based Compensation of $1.2 million for Q1 2026, up 17.37% on a YoY basis from $1.0 million in Q1 2025, and down 66.16% sequentially from $3.6 million in Q4 2025.
Rapid Micro Biosystems (RPID) Share-based Compensation (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Share-based Compensation data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 17.37% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 9900.0% YoY), and the FY2025 full-year result was $4.0 million, changed N/A from the prior year.
- Share-based Compensation eased to $1.2 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $6.9 million in Q1 2022 to a low of -$4.7 million in Q3 2022.
- A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 3529.32% in 2022, while the deepest fall reached 175.66% in 2022.
- Tracing RPID's Share-based Compensation over 5 years: stood at $4.7 million in 2022, then dropped by 1.96% to $4.6 million in 2023, then sank by 149.05% to -$2.3 million in 2024, then soared by 260.2% to $3.6 million in 2025, then slumped by 66.16% to $1.2 million in 2026.
- Business Quant data shows RPID's Share-based Compensation at $1.2 million in Q1 2026, $3.6 million in Q4 2025, and $1000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.22 Mn |
| Mar 31, 2026 | 1.22 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Sep 30, 2024 | -2.26 Mn |
| Sep 30, 2024 | -2.26 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Sep 30, 2023 | -2.33 Mn |
| Sep 30, 2023 | -2.33 Mn |